Free Republic 2nd Quarter Fundraising Target: $88,000 Receipts & Pledges to-date: $83,146
94%  
Woo hoo!! And now less than $4.9k to go!! We can do this. Thank you all very much! God bless.

Keyword: pharmaceuticals

Brevity: Headers | « Text »
  • Senate to take up Trump's call to lower drug prices 'in June'.....

    05/29/2018 12:35:48 PM PDT · by caww · 13 replies
    www.washingtonexaminer ^ | 5/29/2018 | Robert King
    Sign up for Daily on Healthcare Email Address SUBMIT The Senate plans to start working toward new drug price legislation this summer to help President Trump tackle high prices, even though previous bipartisan measures have struggled to get off the ground. Trump’s blueprint issued a few weeks ago includes several proposal, and senators are planning their own legislation to complement the blueprint. The effort will start next month, when the Senate Health, Education, Labor and Pensions Committee hosts Health and Human Services Secretary Alex Azar on June 12 to discuss the blueprint. Chairman Lamar Alexander, R-Tenn., said ideas for new...
  • Trump denounces ‘middlemen,’ largely spares pharma in drug pricing speech

    05/14/2018 6:05:40 PM PDT · by spintreebob · 21 replies
    http://www.modernhealthcare.com/article/20180511/NEWS/180519968 https://www.statnews.com/2018/05/11/trump-drug-pricing-speech/ https://www.scientificamerican.com/article/trump-denounces-middlemen-and-largely-spares-pharma-in-drug-pricing-speech/ http://www.bipc.com/trump-condemns-middlemen-in-drug-pricing-speech-modern-healthcare https://www.washingtonpost.com/news/powerpost/paloma/the-health-202/2018/05/14/the-health-202-health-industry-appears-unfazed-by-trump-s-drug-pricing-speech/5af4ac5530fb042588799464/ http://www.healthleadersmedia.com/health-plans/eliminating-middlemen-trump-takes-aim-pbms-drug-pricing-speech http://www.bipc.com/trump-condemns-middlemen-in-drug-pricing-speech-modern-healthcare
  • Trump's plan to lower drug prices diverges from campaign promise (barf alert)

    05/12/2018 9:18:38 AM PDT · by gattaca · 19 replies
    New York Slimes ^ | 05/11/2018 | Robert Pear
    President Trump vowed on Friday to “bring soaring drug prices back down to earth” by promoting competition among pharmaceutical companies, and he suggested that the government could require drugmakers to disclose prices in their ubiquitous television advertising. But he dropped the popular and populist proposals of his presidential campaign, opting not to have the federal government directly negotiate lower drug prices for Medicare. And he chose not to allow American consumers to import low-cost medicines from abroad. He would instead give private entities more tools to negotiate better deals on behalf of consumers, insurers and employers.
  • Trump will not call for negotiation on Medicare drug prices despite Democratic hopes

    05/11/2018 5:51:04 AM PDT · by GIdget2004 · 15 replies
    The Hill ^ | 05/10/2018 | Peter Sullivan
    President Trump's drug pricing plan will not include a call for Medicare to negotiate drug prices, a leading Democratic idea that Trump previously supported, a senior administration official said Thursday. “We're not calling for Medicare negotiation in the way that Democrats have called for,” the official said on a call with reporters previewing Trump’s speech on drug prices scheduled Friday. However, the official said there will be other proposals to increase competition in Medicare, likely using private sector players rather than Medicare directly negotiating prices. Democrats have been pressuring Trump ahead of his speech to renew his call for Medicare...
  • HHS secretary: Trump wants to go ‘much, much further’ on tackling drug prices...

    05/09/2018 7:02:11 AM PDT · by caww · 14 replies
    Washington Examiner ^ | 5/9/2018 | Robert King
    Trump’s budget proposal set out several reforms for lowering drug prices, including giving low-income seniors free generic drugs. Azar said the agency wants to solve problems such as the high list prices set by drug makers and “seniors" and government programs overpaying for drugs due to the lack of the latest negotiating tools; rising out-of-pocket costs for consumers; and foreign governments free-riding off American investment in innovation.” Azar also touched on the need for greater transparency of prices of healthcare procedures..........“I believe you ought to have the right to know what a procedure is going to cost, and what it’s...
  • Monday Moanin’ - Gotta’ Nuke Something!

    03/19/2018 7:54:04 AM PDT · by NOBO2012 · 2 replies
    MOTUS A.D. ^ | 3-19-18 | MOTUS
    I understand that some Congressmen (by that I mean men and women, I’m unaware of any other “genders” currently serving but if there are, it includes them too) are offering jobs to Andrew McCabe in order to allow him to earn his federal pension. Would have been nice if they’d been similarly concerned about ordinary Americans who lost their jobs, and pensions, during the 8 year Obama occupation.I wish they’d just get back to tending to Global Warming, so the Rothschilds don’t end up running the world – and the weather.But what’s really not what’s bothering me today; number one...
  • Metformin Diabetes Drug Could Extend Lifespan

    02/17/2017 4:45:58 PM PST · by blam · 40 replies
    Medical News Today ^ | 8-8-2014 | Hannah Nichols
    Metformin is approved in the US as a treatment for type 2 diabetes. A new study by Cardiff University, UK, involving over 180,000 people, reveals that the drug could also increase the lifespan of those individuals who are non-diabetics. According to the Centers for Disease Control and Prevention (CDC), there are around 29.1 million people in the US with diabetes, equating to 9.3% of the population. Type 2 diabetes accounts for 90-95% of diabetes cases and is usually associated with older age, obesity and physical inactivity, family history of type 2 diabetes or a personal history of gestational diabetes. Senior...
  • New Antibiotic for MRSA Infections is Ready for US Clinical Trials

    02/27/2018 9:53:11 AM PST · by nickcarraway · 15 replies
    Labiotech ^ | Alex Dale Alex Dale on 26/02/2018 | Alex Dale Alex Dale on 26/02/2018
    Destiny Pharma’s antibiotic for post-surgical infections will begin its clinical development after the FDA accepted its Investigational New Drug application. Destiny Pharma wants to combat the growing antibiotic resistance crisis by targeting post-surgical Staphylococcus aureus infections like methicillin-resistant Staphylococcus aureus (MRSA). The FDA has accepted an investigational new drug application (IND) for Destiny’s MRSA candidate, XF-73, which will allow the company to complete Phase I and finalize the design of a Phase II trial. XF-73 is a dicationic porphyrin molecule, which is a member of a new class of antibiotics called XF drugs. Interestingly, XF-73 is a nasal gel, which...
  • Trump: 'One of My Greatest Priorities Is to Reduce the Price of Prescription Drugs'

    01/31/2018 2:41:27 AM PST · by markomalley · 65 replies
    CNS News ^ | 1/31/18 | Susan Jones
    Almost a year to the day after meeting with pharmaceutical executives at the White House, President Trump is once again calling for lower prescription drug prices. In his State of the Union speech Tuesday night, he said it's one of his highest priorities for the year ahead: "One of my greatest priorities is to reduce the price of prescription drugs," the president said, drawing sustained applause from Republicans. Turning to the Democrat side of the aisle, Trump gestured for the seated lawmakers to join Republicans in their standing ovation. "In many other countries, these drugs cost far less than what...
  • Hurricane Damage in Puerto Rico Leads to Fears of Drug Shortages Nationwide

    10/06/2017 4:01:56 PM PDT · by RightGeek · 31 replies
    NT Times ^ | Oct. 4, 2017 | KATIE THOMAS and SHEILA KAPLAN
    Federal officials and major drugmakers are scrambling to prevent national shortages of critical drugs for treating cancer, diabetes and heart disease, as well as medical devices and supplies, that are manufactured at 80 plants in hurricane-ravaged Puerto Rico. Pharmaceuticals and medical devices are the island’s leading exports, and Puerto Rico has become one of the world’s biggest centers for pharmaceutical manufacturing. Its factories make 13 of the world’s top-selling brand-name drugs, from Humira, the rheumatoid arthritis treatment, to Xarelto, a blood thinner used to prevent stroke, according to a report released last year. With business of nearly $15 billion a...
  • The Swamp Is Incoherent on the Rule of Law, Thanks to Pharma

    09/09/2017 5:42:49 AM PDT · by Kaslin · 10 replies
    Townhall.com ^ | September 9, 2017 | Mytheos Holt
    The bipartisan Washington, DC “consensus” has so many blind spots, you’d think its exponents lived in a black box. Recently, it has become clear that one of the biggest of those blind spots is the federal government’s treatment of the pharmaceutical industry.This can be most clearly seen in the troubling continuity between the favored policy of pharma-friendly elements within the Trump administration, and the Obama administration’s own weakness on a critical policy in the battle over drug prices: namely, the 340B drug pricing program.As granular followers of pharmaceutical policy will already know, 340B is a program passed during the first...
  • .@Merck Pharma is a leader in higher & higher drug prices while (....)taking jobs out of the U.S.

    08/14/2017 3:49:54 PM PDT · by SMGFan · 17 replies
    Real Donald Trump twitter account ^ | August 14, 2017 | President Donald Trump
    .@Merck Pharma is a leader in higher & higher drug prices while at the same time taking jobs out of the U.S. Bring jobs back & LOWER PRICES!
  • Merck CEO resigns from Trump council after Charlottesville

    08/14/2017 7:27:39 AM PDT · by SoFloFreeper · 54 replies
    Reuters ^ | 8/14/17
    Merck & Co Inc Chief Executive Kenneth Frazier resigned from U.S. President Donald Trump's American Manufacturing Council on Monday, saying he was taking a stand against intolerance and extremism.
  • Too Many Meds? America's Love Affair With Prescription Medication

    08/12/2017 8:00:25 PM PDT · by nickcarraway · 39 replies
    Consumer Reports ^ | August 03, 2017 | Teresa Carr
    We now take more pills than ever. Is that doing more harm than good? If you’re like most Americans, you probably start your day with a hot shower, a cup of coffee—and a handful of pills. More than half of us now regularly take a prescription medication—four, on average—according to a new nationally representative Consumer Reports survey of 1,947 adults. Many in that group also take over-the-counter drugs as well as vitamins and other dietary supplements. It turns out Americans take more pills today than at any other time in recent history (see “Pill Nation: The Rise of Rx Drug...
  • 'Pharma Bro' Shkreli is convicted at securities fraud trial

    08/04/2017 12:22:07 PM PDT · by NohSpinZone · 8 replies
    Fox Business News ^ | 8/4/17 | Tom Hays
    Martin Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide "Pharma Bro" persona on social media, was convicted Friday on federal charges he deceived investors in a pair of failed hedge funds.
  • AmbioPharm Invests in $18M Expansion (100 jobs in South Carolina)

    07/21/2017 8:50:11 PM PDT · by 2ndDivisionVet · 1 replies
    Commercial Property Executive ^ | July 21, 2017 | Laura Calugar
    AmbioPharm Inc., a peptide and biopharmaceutical manufacturing company in North Augusta, S.C., plans to expand its existing Aiken County operations. The extension is projected to bring $18 million of new capital investment and lead to the creation of 100 jobs over the next five years. Located at 1024 Dittman Court, AmbioPharm is near Interstate 520. The company will start constructing two additional freestanding buildings, totaling 50,000 square feet, and purchasing additional equipment. The Coordinating Council for Economic Development approved job development credits related to this project. Third SC expansion AmbioPharm started its business in South Carolina 10 years ago by...
  • NPR Talks Smack

    06/30/2017 3:16:13 PM PDT · by yoe · 9 replies
    The Weekly Standard ^ | June 26, 2017 | By The Scrapbook
    Public radio doesn't quite know what it wants us to think about the anti-addiction medicine Vivitrol. At the beginning of the month Marketplace was touting Vivitrol as the "drug that heroin-proofs your brain," a sort of magic bullet for shooting the old monkey off one's back. The drug is essential, we were told, in keeping junkies out of jail. An addiction specialist raved that Vivitrol acts like "a kind of a force field around the part of your brain that likes heroin." The medicine is regularly given to inmates upon release from prison, so they can stay clean: It works...
  • Granules India Expansion Will Create More Than 100 Jobs In Virginia

    05/23/2017 3:08:11 PM PDT · by 2ndDivisionVet · 3 replies
    Business Facilities ^ | May 23, 2017
    Granules India Ltd. will invest $35 million into its subsidiary, Granules Pharmaceuticals Inc., to expand its pharmaceutical R&D and manufacturing capabilities in Fairfax County, VA. Before choosing Virginia, the company also considered New Jersey for the project, which will create 102 new jobs. In 2014, the company invested $15 million to establish its wholly-owned subsidiary operation, creating 75 jobs in Fairfax. India-based Granules India Ltd. manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs), distributed to customers in both regulated and semi-regulated markets. “Setting up a development and manufacturing presence in the United States was the...
  • State: Pharmaceutical Company To Create 361 Jobs In Windsor (Connecticut)

    05/09/2017 2:53:59 PM PDT · by 2ndDivisionVet · 2 replies
    WTIC-AM ^ | May 9, 2017
    WINDSOR, Conn. (CBS Connecticut) – An Arkansas-based pharmaceutical company plans to open a 90,000 square-foot manufacturing facility in Windsor, said the office of Governor Dannel Malloy Tuesday. SCA Pharmaceuticals plans to create 361 jobs at the facility over the next four years, said officials. SCA manufactures injectable pharmaceuticals in ready-to-administer dosages for use at hospitals and healthcare facilities. The company helps healthcare facilities increase efficiencies and reduce costs while improving patient care. SCA is leasing a facility at 755 Rainbow Road in Windsor. The state, through the Department of Economic and Community Development , will support the project with an...
  • How Trump Could Make Your Drugs Cheaper ... If He Dares

    04/24/2017 2:52:04 PM PDT · by 2ndDivisionVet · 13 replies
    OZY ^ | April 21, 2017 | Daniel Malloy, The Daily Dose
    For the more than 3 million Americans infected with potentially deadly hepatitis C, a relatively new cocktail of drugs is considered a miracle cure. The problem: Gilead Sciences’ list price is $84,000 for a 12-week treatment. From Martin Shkreli’s Turing Pharmaceuticals jacking up the AIDS drug Daraprim from $13.50 per pill to $750 in a single day to Mylan’s allergy-fighting EpiPens rising from $100 to $600 in just a few years, Americans are getting sick of astonishing drug prices. It’s why Donald Trump and Bernie Sanders both used their presidential campaigns to roast Big Pharma. In a primary-season rally in...